<?xml version="1.0" encoding="UTF-8"?>
<p>On 31 January 2020, the New England Journal of Medicine reported the diagnosis and treatment of the first SARS-CoV-2 patient in the United States [
 <xref rid="B58-biomolecules-10-01148" ref-type="bibr">58</xref>], and remdesivir exhibited some potential in the treatment of this first patient.
</p>
